Anne-laure Chene

Nantes, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Case Report: Pembrolizumab unmasks a capillary leak syndrome with chylothorax in early TNBC.

Case Report: Pembrolizumab unmasks a capillary leak syndrome with chylothorax in early TNBC.

Journal: Frontiers in oncology

Published: January 12, 2026

Transbronchial lung cryobiopsy: a safe and effective technique in the diagnosis of interstitial lung disease in the older people.

Transbronchial lung cryobiopsy: a safe and effective technique in the diagnosis of interstitial lung disease in the older people.

Journal: BMC geriatrics

Published: February 08, 2024

A Comparative Multicenter Cohort Study Evaluating the Long-Term Influence of the Strict Lockdown during the First COVID-19 Wave on Lung Cancer Patients (ARTEMISIA Trial).

A Comparative Multicenter Cohort Study Evaluating the Long-Term Influence of the Strict Lockdown during the First COVID-19 Wave on Lung Cancer Patients (ARTEMISIA Trial).

Journal: Cancers

Published: November 09, 2023

Use of non-small cell lung cancer multicellular tumor spheroids to study the impact of chemotherapy.

Use of non-small cell lung cancer multicellular tumor spheroids to study the impact of chemotherapy.

Journal: Respiratory research

Published: October 11, 2023

IL-7 is expressed in malignant mesothelioma and has a prognostic value.

IL-7 is expressed in malignant mesothelioma and has a prognostic value.

Journal: Molecular oncology

Published: May 04, 2022

A fatal case associated with Catabacter hongkongensis bacteremia in lung cancer patient: A case report.

A fatal case associated with Catabacter hongkongensis bacteremia in lung cancer patient: A case report.

Journal: IDCases

Published: February 28, 2022

Evaluation of the Post-COVID-19 Functional Status (PCFS) Scale in a cohort of patients recovering from hypoxemic SARS-CoV-2 pneumonia.

Evaluation of the Post-COVID-19 Functional Status (PCFS) Scale in a cohort of patients recovering from hypoxemic SARS-CoV-2 pneumonia.

Journal: BMJ open respiratory research

Published: November 04, 2021

Baseline tumour size is an independent prognostic factor for overall survival in PD-L1 ≥ 50% non-small cell lung cancer patients treated with first-line pembrolizumab.

Baseline tumour size is an independent prognostic factor for overall survival in PD-L1 ≥ 50% non-small cell lung cancer patients treated with first-line pembrolizumab.

Journal: Cancer immunology, immunotherapy : CII

Published: July 17, 2021

Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma.

Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma.

Journal: Journal for immunotherapy of cancer

Published: May 08, 2020

Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer.

Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer.

Journal: The European respiratory journal

Published: April 26, 2020

Pleural adverse drugs reactions and protein kinase inhibitors: Identification of suspicious targets by disproportionality analysis from VigiBase.

Pleural adverse drugs reactions and protein kinase inhibitors: Identification of suspicious targets by disproportionality analysis from VigiBase.

Journal: British journal of clinical pharmacology

Published: April 12, 2018

Brain-derived neurotrophic factor, a new soluble biomarker for malignant pleural mesothelioma involved in angiogenesis.

Brain-derived neurotrophic factor, a new soluble biomarker for malignant pleural mesothelioma involved in angiogenesis.

Journal: Molecular cancer

Published: March 30, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026